Tevimbra is under clinical development by BeiGene and currently in Phase II for Anaplastic Thyroid Cancer. According to GlobalData, Phase II drugs for Anaplastic Thyroid Cancer have a 36% phase ...
One out of every 20 Koreans is a cancer patient. Also, our people had thyroid cancer the most, men had lung cancer and women had breast cancer the most. Reporter Kim Joo-young reports. [Reporter] ...
Mutation-directed targeted therapy in combination with a PD-L1 inhibitor “is a promising strategy” to extend survival in patients with anaplastic thyroid cancer, according to researchers.
The following is a summary of “Medium- and long-term recurrence after radioiodine therapy for differentiated thyroid carcinoma with recombinant human thyrotropin: a meta-analysis,” published in the ...
Differentiated thyroid cancers (DTC) and anaplastic thyroid cancers (ATC) often develop primary and acquired resistance to standard treatments. This highlights the need for new therapeutic strategies ...